A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help users better manage their type 2 diabetes by recommending insulin-dose ...
The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification.
Algorithm with glucose monitor improves insulin dosing and boosts time in safe blood sugar range in type 2 diabetes.
Please provide your email address to receive an email when new articles are posted on . Of 20 hospitals providing insulin algorithms, 60% stated which patients should initiate basal or nutritional ...
A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage ...
The Food and Drug Administration has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with Type 1 diabetes. These two devices, along ...
Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults with Type 2 diabetes. The Control-IQ+ program—now with the added ...
MILPITAS, Calif.--(BUSINESS WIRE)--Bigfoot Biomedical (Bigfoot), a leader in developing intelligent connected injection support systems, today announced the acquisition of a reinforcement learning ...
The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.
MedPage Today on MSN
Obesity Drug Trial Dilemma; Tiny Insulin Pump Cleared; Type 5 Diabetes Deaths
News and commentary from the endocrinology world ...
Adults with type 1 diabetes had an increase in total daily insulin dose and bolus insulin dose shortly after stopping semaglutide therapy, according to a speaker. As Healio previously reported, in a ...
Calcium channel blockers are a common cause of poisoning and are associated with high mortality in affected patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results